Matsuda Masaru insider trades
Matsuda Masaru has filed 32 Form 4s with the SEC that we hold, for Arcutis Biotherapeutics, Inc. (ARQT) (See Remarks) and Halozyme Therapeutics, INC. (HALO) (SVP, General Counsel). Across all of them we count 2 purchases worth $18.5K and 36 sales worth $3.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 18 sales ($2.2M). The largest single trade was a sale of 36,130 shares of Arcutis Biotherapeutics, Inc. worth $583.9K, dated 2025-09-04. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-07 and the latest 2026-09-18.
Arcutis Biotherapeutics, Inc. (ARQT)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-06-02 | S, sale reported on Form 4 | 1,795 | $35.4K | 2022-06-02 | SEC |
| 2022-11-21 | S, sale reported on Form 4 | 1,720 | $31.3K | 2022-11-22 | SEC |
| 2023-03-02 | S, sale reported on Form 4 | 1,416 | $22.4K | 2023-03-06 | SEC |
| 2023-03-02 | S, sale reported on Form 4 | 18 | $297 | 2023-03-06 | SEC |
| 2023-05-31 | S, sale reported on Form 4 | 1,830 | $14.3K | 2023-06-02 | SEC |
| 2023-11-21 | S, sale reported on Form 4 | 1,850 | $3.7K | 2023-11-21 | SEC |
| 2024-03-04 | S, sale reported on Form 4 | 3,760 | $41.8K | 2024-03-06 | SEC |
| 2024-05-02 | S, sale reported on Form 4 | 5,016 | $43.8K | 2024-05-03 | SEC |
| 2024-05-28 | S, sale reported on Form 4 | 1,775 | $16.0K | 2024-05-29 | SEC |
| 2024-05-31 | P, purchase reported on Form 4 | 4,000 | $6.8K | 2024-12-03 | SEC |
| 2024-08-02 | S, sale reported on Form 4 | 5,220 | $47.1K | 2024-08-05 | SEC |
| 2024-11-04 | S, sale reported on Form 4 | 5,015 | $43.5K | 2024-11-05 | SEC |
| 2024-11-19 | S, sale reported on Form 4 | 1,775 | $17.2K | 2024-11-19 | SEC |
| 2024-11-30 | P, purchase reported on Form 4 | 1,657 | $11.8K | 2024-12-03 | SEC |
| 2025-02-03 | S, sale reported on Form 4 | 8,338 | $105.9K | 2025-02-04 | SEC |
| 2025-03-03 | S, sale reported on Form 4 | 3,263 | $42.5K | 2025-03-04 | SEC |
| 2025-05-02 | S, sale reported on Form 4 | 5,030 | $76.5K | 2025-05-05 | SEC |
| 2025-05-28 | S, sale reported on Form 4 | 1,800 | $24.8K | 2025-05-29 | SEC |
| 2025-08-04 | S, sale reported on Form 4 | 6,330 | $90.7K | 2025-08-05 | SEC |
| 2025-09-04 | S, sale reported on Form 4 | 36,130 | $583.9K | 2025-09-08 | SEC |
| 2025-11-03 | S, sale reported on Form 4 | 7,165 | $177.0K | 2025-11-05 | SEC |
| 2025-11-03 | S, sale reported on Form 4 | 43 | $1.1K | 2025-11-05 | SEC |
| 2025-11-19 | S, sale reported on Form 4 | 989 | $27.6K | 2025-11-21 | SEC |
| 2025-11-19 | S, sale reported on Form 4 | 1,561 | $44.5K | 2025-11-21 | SEC |
| 2025-12-01 | S, sale reported on Form 4 | 1,657 | $50.1K | 2025-12-03 | SEC |
| 2026-02-02 | S, sale reported on Form 4 | 7,983 | $203.6K | 2026-02-04 | SEC |
| 2026-02-02 | S, sale reported on Form 4 | 4,714 | $120.8K | 2026-02-04 | SEC |
| 2026-02-02 | S, sale reported on Form 4 | 19,379 | $489.1K | 2026-02-04 | SEC |
| 2026-02-02 | S, sale reported on Form 4 | 8,562 | $213.8K | 2026-02-04 | SEC |
| 2026-02-27 | S, sale reported on Form 4 | 3,325 | $92.9K | 2026-03-03 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 1,987 | $51.1K | 2026-03-03 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 6,553 | $164.9K | 2026-03-03 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 193 | $5.0K | 2026-03-03 | SEC |
| 2026-05-04 | S, sale reported on Form 4 | 7,372 | $171.5K | 2026-05-06 | SEC |
| 2026-05-04 | S, sale reported on Form 4 | 884 | $20.9K | 2026-05-06 | SEC |
| 2026-08-03 | S, sale reported on Form 4 | 1,230 | $32.1K | 2026-08-05 | SEC |
| 2026-09-08 | S, sale reported on Form 4 | 9,989 | $250.0K | 2026-09-10 | SEC |
| 2026-09-16 | S, sale reported on Form 4 | 3,674 | $91.9K | 2026-09-18 | SEC |
Halozyme Therapeutics, INC. (HALO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1798679) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
